Browse studies

Find your next paid study

3,080 recruiting studies matching your filters

MC1684 Phase I Trial of Systemic Administration of Vesicular Stomatitis Virus Genetically Engineered to Express NIS and Human Interferon, in Patients With Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia, Lymphomas, or Histiocytic/Dendritic Cell Neoplasms

This phase I trial studies the best dose and side effects of the VSV-hIFNβ-NIS vaccine with or without cyclophosphamide and combinations of ipilimumab, nivolum…

B-Cell Non-Hodgkin LymphomaHistiocytic and Dendritic Cell NeoplasmMyelodysplastic Syndrome+16 more

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Mayo ClinicNCT03017820

Phase 2

Cancer CARE Beyond Walls - A Pilot of a Randomized, Pragmatic Trial of Cancer Directed Therapy Administration in the Patients' Homes Versus in Clinic

This clinical trial studies the effect of cancer directed therapy given at-home versus in the clinic for patients with cancer that may have spread from where i…

Advanced Anal CarcinomaAdvanced Biliary Tract CarcinomaAdvanced Bladder Carcinoma+41 more

Investigating Metabolic Characteristics of Intracranial Malignancy In Vivo Using Hyperpolarized Carbon-13 Magnetic Resonance Spectroscopic Imaging (MRSI)

This is a non-randomized, purely observational, feasibility study to detect metabolic changes in patients with brain malignancy using a novel hyperpolarized \[…

Brain Tumor Adult

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Texas Southwestern Medical CenterNCT03067467

Preparing a Clinical Outcomes Assessment Set for Nephrotic Syndrome

Researchers from the University of Michigan and Northwestern University are studying people's experiences with swelling caused by Nephrotic Syndrome. Interview…

Fluid OverloadGlomerulosclerosis, Focal SegmentalEdema+10 more

Estimated

~$10 – $750

Actual pay is set by the research site.

University of MichiganNCT05505500

Phase 1

DCE-MRI-Informed Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer

This clinical trial tests how well dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) with standard clinical evaluation works to assess treatment r…

Borderline Resectable Pancreatic Ductal Adenocarcinoma

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Ohio State University Comprehensive Cancer CenterNCT07705919

Phase 3

An Open-Label Prospective Randomized Trial of Family Donor-Derived ADV or CMV CTLs Plus Standard of Care (SOC) vs SOC Alone in Children, Adolescents and Young Adults Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) With Refractory ADV or CMV Infection/Viremia

Patients with refractory ADV or CMV infection post allogeneic stem cell transplant will be randomized to either Family donor-derived viral specific cytotoxic T…

CMVAdV InfectionAdV Reactivation+2 more

Estimated

~$50 – $1,500

Actual pay is set by the research site.

New York Medical CollegeNCT07225972

Observational

Does Leadership Training Affect Physician Career Satisfaction?

The aim of the study is to evaluate the impact of organizational interventions for physician development on wellbeing, and investigate wellbeing and other char…

LeadershipPersonality

Estimated

~$10 – $750

Actual pay is set by the research site.

Methodist Health SystemNCT06222411

Minimal Residual Disease Assessment in Colorectal Cancer (MiRDA-C)

This study investigates if circulating tumor DNA (ctDNA) and other tumor-related molecules/chemicals released in the blood can help doctors predict if colorect…

Colorectal AdenocarcinomaStage I Colorectal Cancer AJCC v8Stage II Colorectal Cancer AJCC v8+11 more

Estimated

~$10 – $750

Actual pay is set by the research site.

M.D. Anderson Cancer CenterNCT04739072

Phase 1

A Phase 1/2, Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, and Preliminary Antitumor Activity of TNG456 Monotherapy and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

This is a first in human study of TNG456 alone and in combination with abemaciclib in patients with advanced or metastatic solid tumors known to have an MTAP l…

Non Small Cell Lung CancerGlioma Glioblastoma MultiformeGlioma, Malignant+4 more

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Tango Therapeutics, Inc.NCT06810544

Observational

Trans STAIR: Implementing an Evidence Based Trauma Treatment With Community Led PrEP Navigation

This pilot trial will leverage "PrEP Well," an ongoing multi-level implementation strategy for providing PrEP in transgender/gender diverse (TGD)-serving conte…

PrEP Uptake ExperiencesPrEP Adherence ExperiencesMental Health Symptoms

Estimated

~$10 – $750

Actual pay is set by the research site.

San Diego State UniversityNCT06724965

Observational

Investigation of Vagus Nerve Stimulation to Augment Executive Functioning

This study plans to learn more about how stimulating the vagus nerve through gentle electrical stimulation applied to the ear can affect decision-making, probl…

Mild Cognitive Impairment (MCI)Parkinsons Disease (PD)Healthy Adult

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Colorado, DenverNCT07424365

Phase 1

A Phase 1/2, Open-Label, Multi-Center, First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of TPX-0005 in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements (TRIDENT-1)

Phase 1 dose escalation will determine the first cycle dose-limiting toxicities (DLTs), the maximum tolerated dose (MTD), the biologically effective dose and r…

Locally Advanced Solid TumorsMetastatic Solid Tumors

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Turning Point Therapeutics, Inc.NCT03093116